Molecular Diagnostics
Next-Generation Multiomics Blood-Based Test for Pancreatic Cancer Could Become Powerful Tool for Early Diagnosis and Treatment
Freenome Holdings, Inc. (South San Francisco, CA, USA) has demonstrated the potential of extending its multiomics approach into other cancers, such as pancreatic cancer, with biomarkers already embedded in the existing platform. More...07 Oct 2021
Liquid Biopsy Test Tracks Treatment-Based ctDNA Changes
Metastatic or unresectable disease is identified in approximately 20% of patients presenting with invasive urothelial cancer. In addition, up to 50% of patients will develop metastases following radical cystectomy for clinically localized disease. More...06 Oct 2021
A Blood-Based Liquid Biopsy Combined with Machine Learning for Early Lung Cancer Diagnosis
A novel liquid biopsy that collects fragments of circulating tumor DNA combined with advanced machine learning technology was able to detect over 90% of lung cancers in samples from nearly 800 individuals with and without the disease. More...05 Oct 2021
Benign Hypertension-Causing Tumors Linked to Somatic Co-Driver Mutations
Most aldosterone-producing adenomas (APAs) have gain-of-function somatic mutations of ion channels or transporters. However, their frequency in aldosterone-producing cell clusters of normal adrenal gland suggests a requirement for co-driver mutations in APAs. More...05 Oct 2021
Next Generation Rapid Antibiotic Susceptibility Testing (AST) Platform Granted FDA Breakthrough Device Designation
Selux Diagnostics, Inc.’s (Boston, MA, USA) Next Generation Phenotyping (NGP) platform has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for positive blood culture and sterile body fluid samples. More...05 Oct 2021
In Other News
IFN-γ Signature Distinguishes Pediatric Hemophagocytic Lymphohistiocytosis from Sepsis and SIRS
Liquid Bioassay for Ultrasensitive Detection of Circulating HPV DNA
New Non-Invasive Blood Test for Colon Cancer Presented at 2021 AACC Annual Scientific Meeting
Seegene Unveils New STARlet-AIOS All-in-One Solution for All Molecular Testing at AACC 2021
Visby Medical Presents New Portable PCR COVID-19 Test Kit at 2021 AACC Annual Scientific Meeting & Clinical Lab Expo
Mammoth Biosciences Presents AACC 2021 Disruptive Technology Award Finalist CRISPR-Based Detection Platform
Hologic Displays Automated Solutions And Expansive Diagnostic Menu to Help Labs Grow at AACC 2021
Bioperfectus Demonstrates Nucleic Acid Extraction Solutions at AACC 2021
Abbott Demonstrates Core Diagnostics Solutions Consisting of Innovative Systems, Automation and Informatics at AACC 2021
Novel Tool Developed to Detect and Identify Pathogens
Placental MicroRNAs Diagnosis Pregnancy Progress and Fetal Distress
Thermo Fisher Presents Newest LC-MS/MS Instrumentation and Latest Innovations in Molecular Diagnostics
Clear Labs Introduces Clear Dx SARS-CoV-2 Solution That Addresses and Overcomes Traditional Barriers to NGS
Randox Showcases Pioneering Diagnostic Technologies at 2021 AACC Clinical Lab Expo
Saliva-Based Liquid Biopsy Detects HPV-Caused Head and Neck Cancers
Automated Detection of Arm-Level Alterations for Individual Cancer Patients
Serum Levels of Thymidine Kinase Predict Disease Progression and Overall Survival of Metastatic Breast Cancer Patients
Certest Offers Real-Time PCR Assays for Fast Detection of MDR Bacterial Infections
Thermo Fisher Launches World’s First Fully Integrated Digital PCR (dPCR) System
Thermo Fisher Launches World’s First Fully Integrated Digital PCR (dPCR) System
Metabolic Biomarker Panel Shows Promise for Diagnosis of Dementia
Acute Lymphoblastic Leukemia Risk Linked to Genetically Mediated Increase in Lymphocytes
Biomarkers Found for COVID-19 MIS-C Condition in Children
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.